The 20 Best Myelodysplastic Syndrome (MDS) Doctors Near Me in Monroeville, PA

Dhaval R. Mehta, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Mehta treats all types of cancer and has special interest in hematological disorders and solid tumors, and clinical trials in the community setting. Dr. Mehta is rated as an Advanced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Polycythemia Vera, Paget Disease of the Breast, Familial Pancreatic Cancer, and Neuroendocrine Tumor. Dr. Mehta is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine. Dr. Mehta is currently accepting new patients.

Khanh Nguyen, MD, specializes in medical oncology and practices with UPMC Hillman Cancer Center and is affiliated with UPMC East and UPMC Magee-Womens Hospital. Dr. Nguyen completed his medical education at the Medical College of Georgia and is board certified in Medical Oncology by the American Board of Internal Medicine. Dr. Nguyen is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma. Dr. Nguyen is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Nguyen is currently accepting new patients.

Nishant Tageja, MD, is a medical oncologist and hematologist. Dr. Tageja specializes in the treatment of solid tumors such as breast cancer, lung cancer, and colon cancer as well as treatment of all benign and malignant blood disorders including lymphoma, leukemia, and myeloma. Dr. Tageja is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Smoldering Multiple Myeloma, Familial Colorectal Cancer, Breast Cancer, Small Cell Lung Cancer (SCLC), and Bone Marrow Transplant. Dr. Tageja is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine. Dr. Tageja is currently accepting new patients.

Andrew D. Laman, MD, is a hematologist and oncologist at UPMC Hillman Cancer Center. Dr. Laman specializes in hematology and medical oncology. Dr. Laman is rated as an Advanced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, and Small Cell Lung Cancer (SCLC). Dr. Laman is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Laman is currently accepting new patients.

James M. Rossetti, DO, is a hematologist specializing in the treatment of hematological malignancies and myeloid diseases, including myelodysplasia, acute myeloid leukemia, and myeloproliferative neoplasm. He also specializes in cellular therapy. Dr. Rossetti is a referral physician for the UPMC MDS Center of Excellence. Dr. Rossetti is rated as an Advanced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Multiple Myeloma, Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Rossetti is board certified in American Board Of Internal Medicine. Dr. Rossetti is currently accepting new patients.

Jing-Zhou Hou, MD, PhD, is a clinical hematological oncologist specializing in hematological malignancies, cell therapy, and bone marrow transplant in the Mario Lemieux Center for Blood Cancers at UPMC Hillman Cancer Center. Dr. Hou received his medical degree from Henan Medical University in China, his master’s degree at Shanghai Medical University, and his PhD in Molecular and Cell Biology from Tulane University. He completed his internal medicine residency in Northeastern Ohio University College of Medicine, and fellowship in Hematology and Oncology at Stanford University. He joined UPMC Hillman Cancer Center in 2007. Dr. Hou is rated as an Advanced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Hou is board certified in American Board Of Internal Medicine. Dr. Hou is currently accepting new patients.

Valerie Wislo, MD, specializes in family medicine and is certified in family medicine by the American Board of Family Medicine. Dr. Wislo received her medical degree from the West Virginia University School of Medicine and completed her residency at UPMC St. Margaret. Dr. Wislo’s clinical interests include treatment of opiate use disorder and the use of medical marijuana. View the full list of Dr. Wislo’s publications on PubMed. Dr. Wislo is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her clinical expertise encompasses Myelodysplastic Syndrome (MDS) and Obesity in Children. Dr. Wislo is board certified in American Board Of Family Medicine. Dr. Wislo is currently accepting new patients.

Stanley Marks, MD, specializes in hematology oncology and medical oncology and is board-certified in hematology and internal medicine by the American Board of Internal medicine. Dr. Marks completed his medical degree at the University of Pittsburgh School of Medicine. He completed his residency training at Presbyterian Hospital, and fellowship training in clinical medicine and research medicine at Peter Bent Brigham Hospital, Harvard Medical School and Dana Farber Cancer Center. He has received numerous awards including the Golden Apple Award for Outstanding Dedication to Housestaff Education from Allegheny General Hospital, Hillel Academy Outstanding Alumnus, and The Winged Victory of Samothrace Award from the Leukemia, Lymphoma Society of Western Pennsylvania. Dr. Marks is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Primary Lymphoma of the Brain, Gastric Lymphoma, and Follicular Lymphoma. Dr. Marks is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine.

Dr. Kane has practiced for more than 20 years and is board certified in Medical Oncology. He received his medical degree from Ohio State University School of Medicine. He completed his residency training in Hematology/Oncology at the University of Pittsburgh School of Medicine. Dr. Kane is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Essential Thrombocythemia, Small Cell Lung Cancer (SCLC), and Familial Colorectal Cancer. Dr. Kane is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Kane is currently accepting new patients.

Jason Bierenbaum, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Bierenbaum specializes in lung cancer, gastrointestinal cancers, and myelodysplasia. Dr. Bierenbaum is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Familial Colorectal Cancer, Lung Cancer, and Pleuropulmonary Blastoma. Dr. Bierenbaum is board certified in American Board Of Internal Medicine. Dr. Bierenbaum is currently accepting new patients.

Hongmei Liang, MD, PhD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center at UPMC St. Margaret. Board certified in internal medicine and medical oncology, Dr. Liang received her medical degree from Shandong Medical University, Jinan in Shandong, China and PhD in immunology at the University of Pittsburgh School of Medicine. She completed her residency in internal medicine at Greater Baltimore Medical Center in Maryland and fellowship in hematology and oncology at the University of Pittsburgh Medical Center. Dr. Liang is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Childhood Iron Deficiency Anemia, and Pleuropulmonary Blastoma. Dr. Liang is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Liang is currently accepting new patients.

John Lech, DO, is a hematologist/medical oncologist at UPMC Hillman Cancer Center. He specializes in the treatment of gastrointestinal malignancies and peritoneal carcinomas. Dr. Lech is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Pleuropulmonary Blastoma. Dr. Lech is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Lech is currently accepting new patients.

Kelly G. Ross, MD, specializes in hematology oncology and is board-certified in hematolgoy and medical oncology by the American Board of Internal Medicine. She is affiliated with UPMC Shadyside and UPMC Presbyterian. Dr. Ross completed her fellowship at the University of Colorado and residency and medical degree at the University of Pittsburgh School of Medicine. Dr. Ross is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Mantle Cell Lymphoma (MCL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Ross is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine.

Robert Redner is a Hematologist Oncology provider practicing medicine in Pittsburgh, Pennsylvania. Dr. Redner is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Acute Promyelocytic Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Redner is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine. Dr. Redner is currently accepting new patients.

Alison Sehgal, MD, is an assistant professor of medicine at the University of Pittsburgh School of Medicine, and a hematologist/medical oncologist specializing in allogeneic and autologous stem cell transplant, lymphoma, leukemia, and multiple myeloma. Dr. Sehgal is conducting research in stem cell transplant and drug development in hematologic malignancies. Dr. Sehgal is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), B-Cell Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Sehgal is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Sehgal is currently accepting new patients.

Annie Im, MD, is an Associate Professor of Medicine at the University of Pittsburgh School of Medicine, and a hematologist/medical oncologist specializing and conducting research in hematologic malignancies (such as acute leukemia), drug development, stem cell transplantation, and graft-versus-host-disease. In addition, Dr. Im leads the chronic graft-versus-host-disease and stem cell transplant survivorship clinic. Dr. Im is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Im is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Im is currently accepting new patients.

Dan P. Zandberg, MD, is an associate professor of medicine and a medical oncologist/hematologist, specializing in the treatment of head and neck and thyroid cancers. He is the Director of the Head and Neck and Thyroid Cancer disease sections for the division of Hematology/Oncology and the Medical Oncology Co-Leader of the UPMC Hillman Head and Neck Cancer Program. He is also the physician lead for the second floor Hillman Cancer Center clinic. His main research focus is in the development of clinical trials with immunotherapy to improve patient outcomes. Recent awards include the 2019 National Cancer Institute (NCI) Cancer Clinical Investigator Team Leadership Award, 2020 Leo Criep, M.D. Excellence in Patient Care Award, and 2020/2021 Castle Connolly Regional Top Doctor. Dr. Zandberg is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Oral Squamous Cell Carcinoma, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma. Dr. Zandberg is board certified in American Board Of Internal Medicine. Dr. Zandberg is currently accepting new patients.

Sawa Ito, MD, PhD, specializes in hematology oncology and medical oncology and is board-certified by the American Board of Internal Medicine. She practices at UPMC Hillman Cancer Center and is affiliated with UPMC Presbyterian, UPMC Magee-Womens Hospital, and UPMC Shadyside. Dr. Ito received her medical degree from Hokkaido University and completed residencies at Teine Keijinkai Hospital and the University of Pittsburgh School of Medicine, followed by a fellowship at the National Institutes of Health. Dr. Ito is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Graft Versus Host Disease (GvHD), Multiple Myeloma, Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Ito is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine. Dr. Ito is currently accepting new patients.

Warren D. Shlomchik, MD, is professor of medicine and immunology at the University of Pittsburgh School of Medicine. He is director of Hematopoietic Stem Cell Transplant and Cell Therapy and scientific director of the Hematopoietic Malignancy Program at UPMC Hillman Cancer Center. Dr. Shlomchik;s research is dedicated to understanding the complex immunology of allogeneic hematopoietic stem cell transplantation (alloSCT), including graft-versus host disease (GVHD), graft-versus-leukemia (GVL), and immune reconstitution. Read more about Dr. Shlomchik's research. Dr. Shlomchik is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Shlomchik is board certified in American Board Of Internal Medicine. Dr. Shlomchik is currently accepting new patients.

Kathleen Dorritie, MD, is a hematologist/medical oncologist at UPMC Hillman Cancer Center specializing in hematologic malignancies and stem cell transplantation. Her research focuses on early phase clinical trials for lymphoid malignancies. She has been very involved in the development of the CAR T-cell program at UPMC and has also worked to develop a stem cell transplant program for hemoglobinopathies, including sickle cell disease. Dr. Dorritie is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), B-Cell Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Dorritie is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Dorritie is currently accepting new patients.